Cargando…
The V654A second-site KIT mutation increases tumor oncogenesis and STAT activation in a mouse model of gastrointestinal stromal tumor
Gastrointestinal stromal tumor (GIST) is the most common human sarcoma and arises in the gastrointestinal tract. Most GISTs are caused by activating mutations in the KIT receptor tyrosine kinase, such as the exon 11 KIT V559Δ mutation. The small molecule imatinib inhibits KIT and has been a mainstay...
Autores principales: | Zhang, Jennifer Q., Bosbach, Benedikt, Loo, Jennifer K., Vitiello, Gerardo A., Zeng, Shan, Seifert, Adrian M., Medina, Benjamin D., Param, Nesteene J., Maltbaek, Joanna H., Rossi, Ferdinand, Antonescu, Cristina R., Besmer, Peter, DeMatteo, Ronald P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7718339/ https://www.ncbi.nlm.nih.gov/pubmed/33024275 http://dx.doi.org/10.1038/s41388-020-01489-4 |
Ejemplares similares
-
ETV4 collaborates with Wnt/β-catenin signaling to alter cell cycle activity and promote tumor aggressiveness in gastrointestinal stromal tumor
por: Zeng, Shan, et al.
Publicado: (2017) -
Oncogenic kinase inhibition limits Batf3-dependent dendritic cell development and antitumor immunity
por: Medina, Benjamin D., et al.
Publicado: (2019) -
KIT oncogene inhibition drives intratumoral macrophage M2 polarization
por: Cavnar, Michael J., et al.
Publicado: (2013) -
ETV1 is a lineage-specific survival factor in GIST and cooperates with KIT in oncogenesis
por: Chi, Ping, et al.
Publicado: (2010) -
Involvement of STAT5 in Oncogenesis
por: Halim, Clarissa Esmeralda, et al.
Publicado: (2020)